Unlock and Upgrade

Remove all limits from your Quizzes

You've reached the limit of our free version but can immediately unlock and go pro.

Continue No thanks

Make your own Quiz

Make your own Quiz Copy & Edit

Make your own quiz Manage my Quizzes Plans / Features Guides and Help Contact Privacy & Security

GIO/Q

Finance awarness Quizz

What is GIO ambition by 2020?

Reduction of the opex by 20%

Reduction of the cost of sales by 20%

Increase of the volume by 10% year on year

Reduction of the cost per dose sold by 20%

What percentage of the final SPC is related to R&D?

1-10%

11%-20%

21%-30%

The same material produced at two different production sites will have the same SPC...

True

False

Depreciation represents ..... % of the overall CGS (Cost of Good Sold)

0-5%

6-10%

11%-15%

16%-20%

For a vaccine costing €2/dose for a 1 dose presentation, how much does the cost per dose approx. Decrease for a two dose presentation?

2€ / dose

1,5€ / dose

1€ / dose

No change

GSK Vaccines has invested massively in fixed assets, what would you expect as an impact on Vaccines balance sheet and P&L?

Balance Sheet: decrease in the fixed asset

P&L: decrease in the operating profit in the short term

P&L: decrease of the depreciations

When is production recognized in the P&L as CGS (Cost of Good Sold)?

Once it is produced

Once it is sold

Once it is recognized in the Balance sheet

{"name":"GIO\/Q Finance awarness Quizz", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"How did GSK Free Cash Flow evolved over last 5 years?, What are the components of the free cash flow?, According to you, what was the main reason of the decrease of the free cash flow?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}